Mometason Bei Heuschnupfen 1 A Pharma (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Mometason Bei Heuschnupfen 1 A Pharma, is a glucocorticoid presented as a nasal spray for nasal administration. It provides anti‑inflammatory relief for allergic rhinitis (Heuschnupfen) in individuals suffering from seasonal or perennial pollen allergies.

GNH USA supplies Mometason Bei Heuschnupfen 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance for global distribution across multiple regions through reliable logistics.

Mometasone furoate nasal spray is used to manage inflammatory processes in the nasal passages associated with allergic rhinitis.

Allergic rhinitis (seasonal): reduces nasal inflammation, congestion, sneezing and itching during pollen season. Allergic rhinitis (perennial): provides sustained symptom relief for year‑round allergen exposure. Nasal symptoms of pollen allergy: alleviates runny nose, post‑nasal drip and throat irritation caused by allergic triggers.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Sore throat - Cough - Altered taste perception

Serious or Rare Side Effects: - Nasal septal perforation - Adrenal suppression with prolonged high‑dose use - Glaucoma or cataract formation - Severe allergic reaction (anaphylaxis)

Before using Mometasone furoate nasal spray, consider the following precautions.

Pregnancy: consult a healthcare provider as safety data are limited. Pediatric use: safety not established for children under 12 years of age. Concomitant nasal surgery: postpone use until postoperative healing is complete. Systemic corticosteroid therapy: monitor for additive immunosuppressive effects. Active nasal infection: avoid use if a bacterial or fungal infection is present. Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure. - Live vaccines: risk of systemic immunosuppression.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: additive immunosuppressive effect. - Azole antifungals (e.g., fluconazole): may raise steroid levels. - Protease inhibitors (e.g., ritonavir): potential increase in glucocorticoid concentration.